Why Healthcare Providers are Well Positioned to Talk to Patients About Medical Marijuana
Clinical Therapeutics · Published 2026-07-01 · DOI 10.1016/j.clinthera.2026.06.009
Authors (1)
Christine Baily
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Baily, C. (2026). Why Healthcare Providers are Well Positioned to Talk to Patients About Medical Marijuana. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2026.06.009
Related articles
- Cannabis Research, Policy, and Therapeutics: An International Quasi-Experiment in Cannabis Policy—Part 2 (2026) · Clinical Therapeutics · 2026 · Cites or is cited by this article · Same journal
- Mycotoxin Trends of Cannabis Compliance Testing in Cannabis Flower and Concentrates in the United States · Clinical Therapeutics · 2026 · Same journal
- Early-Onset Cannabis Use, Retinal Biomarkers, and Risk for Schizophrenia Preliminary Study · Clinical Therapeutics · 2026 · Same journal
- Novel Therapeutic Treatments in Perinatal Genetics Bridging Prenatal and Postnatal Care of Genetic Conditions · Clinical Therapeutics · 2026 · Same journal
- Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader–Willi Syndrome: Results From the Randomized, Placebo-Controlled, Phase 3 Compass PWS Study · Clinical Therapeutics · 2026 · Same journal
- Implications of TLR4 Polymorphisms for Precision Therapeutics in Gram-negative Infections: An Ethnogeographic-Stratified Meta-Analysis · Clinical Therapeutics · 2026 · Same journal
- Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitors in NSCLC: Insights From Pharmacovigilance Data, a Retrospective Case-control Study, and Single-cell RNA Sequencing Dataset · Clinical Therapeutics · 2026 · Same journal
- Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research · Clinical Therapeutics · 2026 · Same journal
- Benefits of Medical Cannabis in Patients With Pain Registered in the Minnesota Medical Cannabis Program · Clinical Therapeutics · 2026 · Same journal
- A Simultaneous Assessment of Efficacy and Safety of Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease · Clinical Therapeutics · 2026 · Same journal